Category: Pharmaceuticals
United States Pharmaceuticals
-
Business Jets
... CAGR of 5.2% over the analysis period 2024-2030. Large Jets, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$19.8 Billion by the end of the analysis ... Read More
-
Hybrid and Electric Vehicle Fuses
... Billion by 2030, growing at a CAGR of 24.4% over the analysis period 2024-2030. Hybrid Electric Vehicles (HEVs), one of the segments analyzed in the report, is expected to record a 25.2% CAGR and reach ... Read More
-
Home Care Services
... at a CAGR of 7.3% over the analysis period 2024-2030. Maid Services, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$22.7 Billion by the end of ... Read More
-
Hair Transplant Services
... at a CAGR of 14.2% over the analysis period 2024-2030. Platelet-Rich Plasma, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$7.0 Billion by the end of ... Read More
-
Generic Drugs
... CAGR of 6.5% over the analysis period 2024-2030. Small-Molecule Generics, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$538.8 Billion by the end of the analysis ... Read More
-
Soldier Systems
... CAGR of 4.8% over the analysis period 2024-2030. Personal Protection, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$3.8 Billion by the end of the analysis ... Read More
-
Cognitive Computing
... CAGR of 27.6% over the analysis period 2024-2030. Natural Language Processing, one of the segments analyzed in the report, is expected to record a 25.1% CAGR and reach US$159.0 Billion by the end of the ... Read More
-
Healthcare Distribution
... CAGR of 13.5% over the analysis period 2024-2030. Pharmaceutical, one of the segments analyzed in the report, is expected to record a 13.3% CAGR and reach US$2.3 Trillion by the end of the analysis period. ... Read More
-
COVID-19 Testing
... CAGR of -15.7% over the analysis period 2024-2030. RT-PCR Assay Kits, one of the segments analyzed in the report, is expected to record a -16.5% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
Flea and Tick Products
... 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Chewable, one of the segments analyzed in the report, is expected to record a 7.5% CAGR and reach US$7.3 Billion by the end ... Read More
-
STD Testing
... CAGR of 5.2% over the analysis period 2024-2030. Chlamydia, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$40.6 Billion by the end of the analysis period. ... Read More
-
Counter Terror and Public Safety Technology
... reach US$532.3 Billion by 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Cyber Security, one of the segments analyzed in the report, is expected to record a 10.7% CAGR and reach ... Read More
-
Gluten Free Products
... at a CAGR of 5.9% over the analysis period 2024-2030. Bakery Products, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.7 Billion by the end of ... Read More
-
Family Planning Centers
... at a CAGR of 3.3% over the analysis period 2024-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion by the end ... Read More
-
Photography Equipment
... CAGR of -9.2% over the analysis period 2024-2030. Cameras, one of the segments analyzed in the report, is expected to record a -10.4% CAGR and reach US$2.1 Billion by the end of the analysis period. ... Read More
-
Pectin
... 5.0% over the analysis period 2024-2030. Food & Beverage, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$904.0 Million by the end of the analysis period. ... Read More
-
Library Furniture
... CAGR of 8.7% over the analysis period 2024-2030. Tables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.9 Billion by the end of the analysis period. ... Read More
-
Human Papillomavirus (HPV) Testing
... 2030, growing at a CAGR of 6.2% over the analysis period 2024-2030. Hospitals & Clinics, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$919.4 Million by ... Read More
-
Gensets
... 5.6% over the analysis period 2024-2030. Diesel, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.1 Billion by the end of the analysis period. Growth in ... Read More
-
Home Cleaning Services
... at a CAGR of 6.6% over the analysis period 2024-2030. The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 9.1% CAGR The Home Cleaning Services market in the U.S. ... Read More
-
Therapeutic Respiratory Devices
... at a CAGR of 3.3% over the analysis period 2024-2030. Positive Airway Pressure Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$32.3 Billion by the ... Read More
-
Probiotics Dietary Supplements
... at a CAGR of 5.8% over the analysis period 2024-2030. Capsules, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by the end of the ... Read More
-
Local Anesthesia Drugs
... at a CAGR of 5.1% over the analysis period 2024-2030. Lidocaine, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Produce Packaging Trays
... at a CAGR of 4.1% over the analysis period 2024-2030. Growers / Shippers, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.0 Billion by the end ... Read More
-
Office Administrative Services
... at a CAGR of 7.9% over the analysis period 2024-2030. Administrative Management Services, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$62.1 Billion by the end ... Read More
Research Assistance
